Blackbaud authorizes $850M common stock repurchase program
Company refreshes buyback authorization in December 2025; $850M remaining as of June 30, 2026. Expects 6–10% repurchase rate in 2026.
What the filing says
Blackbaud announced as of June 30, 2026 that it had approximately $850 million remaining under its common stock repurchase program that was expanded, replenished and reauthorized in December 2025. This authorization enables the company to reduce its share count while generating shareholder value.
The company projects total repurchases during 2026 to represent between 6% and 10% of its outstanding common stock as of December 31, 2025. Year-to-date through June 30, 2026, Blackbaud has already repurchased just over 6% of shares outstanding, reducing total shares by approximately 15% since the fourth quarter of 2023, according to CFO Chad Anderson.
The repurchase activity supports Blackbaud's broader capital allocation strategy, which balances investment in AI innovation, debt service, and shareholder returns. With weighted average diluted shares expected to be 45.0–46.0 million for full-year 2026, continued buybacks will further reduce the share count, which contributes to the company's non-GAAP EPS guidance of $5.15–$5.25 for the full year.
As of June 30, 2026, Blackbaud had approximately $850 million remaining under its common stock repurchase program that was expanded, replenished and reauthorized in December 2025. — BLACKBAUD INC 8-K filing · View on SEC EDGAR →
What this means
Blackbaud's $850 million authorization provides significant flexibility for near-term share count reduction, supporting the company's target of 6–10% repurchases in 2026. Since Q4 2023, the company has already reduced share count by approximately 15%, amplifying the accretion to EPS from operational earnings growth. At June 30, 2026, Blackbaud had 45.5 million shares outstanding (down from 46.7 million at year-end 2025). The authorization size represents roughly 1.9% of the company's current market capitalization (based on stated 2026 diluted weighted average shares of 45–46 million), indicating a measured but meaningful allocation to capital return. The execution mechanism is not specified in the filing.
Frequently asked questions
- When was Blackbaud's $850 million repurchase program authorized?
- The program was expanded, replenished and reauthorized in December 2025, with approximately $850 million remaining available as of June 30, 2026. This represents a fresh authorization that supplements the company's ongoing buyback activities.
- How much has Blackbaud repurchased so far in 2026?
- As of June 30, 2026, Blackbaud had repurchased just over 6% of its outstanding common stock in the first half of 2026. The company has reduced total shares by approximately 15% since Q4 2023, demonstrating sustained and aggressive repurchase activity over the past two years.
- What does Blackbaud expect to repurchase in full-year 2026?
- The company expects total repurchases during 2026 to represent between 6% and 10% of its outstanding common stock as of December 31, 2025. Based on 46.7 million shares outstanding at year-end 2025, this translates to roughly 2.8–4.7 million shares for the full year.
- How does the buyback support Blackbaud's financial guidance?
- Continued share repurchases reduce the diluted weighted average share count (expected to be 45.0–46.0 million in 2026), which provides accretion to non-GAAP EPS guidance of $5.15–$5.25 for full-year 2026. Share count reduction amplifies the impact of operational earnings growth on per-share metrics.
- What execution method does Blackbaud use for repurchases?
- The filing does not specify the execution mechanism (Rule 10b-18 open-market purchases, accelerated share repurchase, or other methods). Blackbaud discloses the authorization and cumulative repurchases but does not detail the specific execution approach in this press release.
- How does Blackbaud balance buybacks with other capital priorities?
- The company balances share repurchases with debt service (interest expense of $62–$66 million expected for 2026), capital expenditures ($60–$70 million), and ongoing investment in AI innovation. Strong free cash flow generation ($280–$290 million projected for 2026) supports this multi-faceted capital allocation strategy.